Production (Stage)
Ultralife Corporation
ULBI
$5.46
-$0.07-1.27%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 21.03% | -1.56% | -9.61% | 0.68% | 31.37% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.03% | -1.56% | -9.61% | 0.68% | 31.37% |
| Cost of Revenue | 24.77% | 0.32% | -9.09% | -2.13% | 24.42% |
| Gross Profit | 11.12% | -7.04% | -11.17% | 9.21% | 54.25% |
| SG&A Expenses | 20.63% | 17.96% | 0.87% | 9.80% | 5.08% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.71% | 4.23% | -6.48% | 0.10% | 18.73% |
| Operating Income | -13.27% | -66.46% | -64.36% | 6.88% | 15,526.92% |
| Income Before Tax | -32.19% | -84.10% | -79.82% | -18.57% | 870.73% |
| Income Tax Expenses | -19.35% | -0.38% | -83.41% | -37.96% | 628.57% |
| Earnings from Continuing Operations | -35.30% | -91.82% | -78.59% | -10.60% | 966.87% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -7.69% | -269.57% | -177.78% | -200.00% | -18.18% |
| Net Income | -35.49% | -93.25% | -80.60% | -11.11% | 935.55% |
| EBIT | -13.27% | -66.46% | -64.36% | 6.88% | 15,526.92% |
| EBITDA | -3.02% | -47.93% | -43.79% | 6.04% | 404.61% |
| EPS Basic | -36.42% | -93.34% | -81.07% | -13.39% | 923.83% |
| Normalized Basic EPS | -29.92% | -88.76% | -68.99% | -21.27% | 827.13% |
| EPS Diluted | -37.61% | -93.70% | -80.63% | -13.39% | 923.83% |
| Normalized Diluted EPS | -29.62% | -88.83% | -69.29% | -22.48% | 821.81% |
| Average Basic Shares Outstanding | 1.45% | 1.78% | 2.38% | 2.65% | 1.62% |
| Average Diluted Shares Outstanding | 0.98% | 1.72% | 3.50% | 4.22% | 2.37% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |